In a controlled experiment, scientists compare a control group and an experimental group that are identical in every respect except for one difference: experimental manipulation.
Differences
Unlike the experimental group, the control group is not exposed to the independent variable under investigation. So, it provides a baseline against which any changes in the experimental group can be compared.
Experimental manipulation is the only difference between the two groups. So researchers can attribute a difference in outcomes to that manipulation rather than to some other factor.
Almost all experimental studies are designed to include a control group and one or more experimental groups. In most cases, participants are randomly assigned to either a control or experimental group.
Random assignment makes this possible. Because chance decides who goes where, researcher bias cannot shape the groups.
Randomisation does not guarantee identical groups, though. Chance imbalances remain common, especially in small samples (Krause & Howard, 2003).
Every aspect of the experimental environment must stay identical for both groups, and experimenters must follow the exact same procedures with each one.
| Control group | Experimental group | |
|---|---|---|
| Independent variable | Not exposed | Exposed to the manipulation |
| Role in the study | Baseline for comparison | The group whose response is tested |
| Drug-trial example | Receives a placebo | Receives the new medication |
| Music-study example | Studies in silence | Studies with music playing |
| Number per study | One or more | One or more |
| Everything else | Identical environment and procedures | Identical environment and procedures |
Control Group
A control group consists of participants who do not receive any experimental treatment. The control participants serve as a comparison group.
The control group should be comparable to the experimental group on characteristics such as age, gender, social class, and ethnicity. Random assignment usually achieves this. It spreads individual differences across both groups by chance, rather than matching participants one by one.
The difference between the control and experimental groups is that the control group is not exposed to the independent variable. That variable is thought to cause the behavior being investigated.
Researchers will compare the individuals in the control group to those in the experimental group to isolate the independent variable and examine its impact.
The control group serves as a baseline. This lets researchers see what impact changes to the independent variable produce, and draw firmer conclusions from a study.
Without a control group, the picture is incomplete. A researcher cannot determine whether a particular treatment truly affected the experimental group.
Control groups are critical to the scientific method as they help ensure a study’s internal validity. Internal validity is the confidence that the independent variable, not some other factor, produced the result.
Example
Assume you want to test a new medication for ADHD. Researchers split participants into two groups.
One group receives the new medication. The other group receives a placebo: a pill that looks identical but contains no active ingredient.
The placebo group is the control group. It exists for a reason. People often feel better simply from believing they have taken a treatment, not from the treatment itself.
Comparing the medication group against the placebo group, rather than against no treatment at all, lets researchers isolate the drug’s real effect from participants’ expectations.
That is why well-designed drug trials often have three arms: active treatment, no treatment, and placebo. Treatment versus placebo isolates the drug’s chemical effect. Placebo versus no treatment isolates the effect of belief.
Beecher’s classic study shows why.
- Aim: Henry Beecher, an anaesthesiologist, wanted to find out how large and how reliable placebo responses really were across medical practice.
- Method: Beecher (1955) reviewed 15 published clinical studies in which patients received a placebo instead of an active treatment, covering conditions including post-operative pain, seasickness, and anxiety.
- Results: On average, placebos helped about 35% of patients. That proportion was comparable, in some studies, to a meaningful fraction of the active drug’s own effect.
- Conclusion: Beecher concluded that the placebo response was real and measurable, not simply “no effect.” He used the finding to argue for placebo control groups in clinical trials.
Beecher’s 35% figure has since been challenged.
Later analysts noted that his pooled studies mixed genuine placebo responses with natural recovery, regression to the mean, and reporting bias. So 35% is best read as an upper limit on the apparent placebo response.
Even so, his core argument still holds: an apparent treatment effect cannot be trusted without a placebo comparison.
The placebo response is also more than a statistical artefact. Wager and Atlas (2015) review evidence that expectation engages real neurobiological systems, including opioid and dopamine pathways, and that placebo analgesia reduces pain-related neural signalling.
Types of Control Groups
Positive Control Group
-
- Definition: A positive control group is an experimental condition expected to produce a known effect, confirming that the experimental procedure itself is capable of detecting a real effect.
- Purpose: It rules out the possibility that a “no effect” result reflects an insensitive experimental setup rather than a genuinely ineffective treatment.
- Example: When testing a new medication, an already licensed medication can serve as the positive control.
Negative Control Group
-
- Definition: A negative control group is an experimental condition expected to produce no effect, confirming that any change seen elsewhere is not simply an artifact of the procedure.
- Purpose: It helps rule out factors other than the treatment, such as participants’ expectations, as the true cause of any observed change.
- Example: A placebo group in a medication trial commonly serves as the negative control.
Other Types of Control Group
Positive and negative controls are not the only options. Placebo, waitlist, and attention-control conditions each isolate a different influence on participants’ responses.
| Control type | What participants receive | What it isolates |
|---|---|---|
| Positive | A treatment already known to work | Whether the procedure can detect a real effect |
| Negative | No treatment, or an inert one | Whether the procedure alone changes the outcome |
| Placebo | An inert treatment that looks identical to the real one | The effect of expecting to be treated |
| Waitlist | No treatment until the trial ends | Natural change over time without treatment |
| Attention control | The same contact time and structure, without the active ingredient | The effect of simply receiving attention |
Waitlist Control
A waitlist control delays treatment rather than withholding it. Participants receive nothing during the trial but are offered the intervention afterwards. It is the usual control in psychotherapy trials, where an inert placebo therapy is rarely practical.
The convenience has a cost. Cuijpers et al. (2024) compared 333 randomised trials of psychotherapy for depression (472 comparisons, 41,480 participants). Trials with a waitlist control reported larger treatment effects than trials with a care-as-usual control:
- Waitlist trials: average effect size g = 0.95.
- Care-as-usual trials: average effect size g = 0.63.
- Improvement in the control arm: g = 0.37 on a waitlist, g = 0.64 on usual care.
The therapy groups themselves improved by similar amounts in both kinds of trial. The gap arose because waiting participants improved less, consistent with waiting itself suppressing natural recovery.
A control group is therefore not simply “untreated”. Its own trajectory has to be examined, not assumed to be a neutral baseline.
Attention Control
People often change their behaviour simply because they know they are being studied. This is the Hawthorne effect, named after productivity studies at the Western Electric Hawthorne Works in the late 1920s and early 1930s (Roethlisberger & Dickson, 1939). How large the effect really is remains debated.
An attention-control condition guards against it. The control group gets the same amount of researcher contact and structure as the experimental group, minus the active ingredient.
Hatzigeorgiadis et al. (2009) used this logic to test whether self-talk improves tennis performance. Young Greek players were randomly allocated to one of two training sessions. One introduced self-talk cues. The other matched it in length and structure but covered only the mechanics of the forehand.
Because both groups received equal coaching attention, any performance difference could be attributed to self-talk rather than to being trained and watched.
Building a credible attention control is harder than it sounds. Nelson et al. (2025), who designed one from a bundle of TED Talks for a clinical trial, set out four requirements:
- Equivalent attention: match contact time, staff attention, and setting to the intervention.
- Engagement: use content interesting enough to hold participants and limit dropout.
- Standardisation: deliver it the same way every time, to avoid confounding the outcome.
- Expectancy: formally evaluate what participants expect, rather than assuming it matches.
Experimental Group
An experimental group consists of participants exposed to a particular manipulation of the independent variable. These are the participants who receive the treatment of interest.
Researchers will compare the responses of the experimental group to those of a control group to see if the independent variable impacted the participants.
An experiment must have at least one control group and one experimental group. A single experiment can include several experimental groups, all compared against the control group.
Multiple experimental groups test different levels of a variable. Researchers compare each level against the control group and against each other.
Example
Assume you want to find out whether listening to music affects focus while studying.
You randomly assign participants to one of three groups:
- Experimental group 1: listens to music with lyrics while studying.
- Experimental group 2: listens to music without lyrics.
- Control group: studies with no music at all.
Both music groups are compared against the no-music baseline, and against each other.
Control and Experimental Groups in Practice
The same logic runs well beyond the psychology laboratory:
- Medicine: The randomised, placebo-controlled, double-blind trial is the regulatory standard for new drugs and therapies. It combines random allocation, a placebo arm, and blinding.
- Education: Torgerson and Torgerson (2001) argue that randomly allocating classes or schools to a new method tests it with the same rigour as a drug trial.
- Online testing: Technology companies randomly show visitors one version of a page or feature (an A/B test) and compare results against an unchanged control version (Kohavi et al., 2013).
Control is harder to apply in sport. A coach cannot easily withhold a method believed to work from an elite athlete, so researchers often compare each athlete’s own performance across conditions instead.
Critical Evaluation of Control Groups
Control groups do valuable work, but they have real limits. The sections below weigh what control buys against what it costs.
Strengths of Control Groups
A control group is what makes a causal claim possible. Without a baseline for comparison, an apparent effect could be a coincidence, a pre-existing group difference, or simply what would have happened anyway.
A simple before-and-after comparison cannot rule these out.
Consider a study that simply measures people before and after a new revision technique, then credits any improvement to the technique itself.
That improvement could equally reflect maturation, extra practice, or students who would have improved anyway, regardless of the technique. Random allocation and a control group rule these out. That is why a well-controlled experiment supports a stronger cause-and-effect conclusion than a simple before-and-after study.
This is the whole toolkit’s payoff.
Limitations of Control
Randomisation has real limits too.
Krause and Howard (2003) examined exactly what random assignment does and does not guarantee.
- Aim: To clarify what random assignment can guarantee in a clinical or psychological trial, correcting a common over-interpretation among researchers.
- Method: A methodological analysis, not new data collection. They worked through the logic and sampling mathematics of random assignment, applied to psychotherapy and clinical trials.
- Results: Random assignment guarantees equivalent groups only on average, across countless hypothetical replications. With realistic sample sizes, chance imbalances are common.
- Conclusion: Randomisation removes systematic bias in group composition, not chance imbalance. A randomised study can still compare groups that differ on an unmeasured variable.
Randomisation therefore means any remaining difference is attributable to chance rather than bias. It does not make the groups identical. A randomised comparison also describes the average participant, not any specific individual.
Tight control also has a cost.
The artificial conditions that make a laboratory experiment easy to control can make the situation participants encounter unlike anything in ordinary life.
Participants often notice this and adjust their behaviour to what they infer the situation demands. Martin Orne (1962) called the cues involved demand characteristics. They include the setting, the instructions, and the researcher’s manner, anything that lets participants guess the study’s hypothesis.
A tightly controlled study can trade away real-world relevance for its internal validity.
Ethical Limits of Placebo Controls
Control conditions can raise ethical problems, not just practical ones. Giving a patient an inert placebo instead of a plausible treatment may mean withholding something they hope will help.
Kobak et al. (2005) show the tension. They randomly assigned 60 people with obsessive-compulsive disorder to 12 weeks of either St John’s wort or a matching placebo. Neither patients nor raters knew who received which.
The herbal remedy did no better than placebo.
Without blinding, hopeful patients and hopeful raters could easily have produced the appearance of an effect. But some patients with a distressing condition went 12 weeks without an active treatment.
Ethical review boards weigh that cost against the alternative. Without a properly blinded placebo comparison, an ineffective treatment could be approved on the strength of expectation alone. The tension is real, and it limits how far placebo control can be pushed when patients have genuine need.
Contemporary Research
For decades, the case for control rested on logic. A newer body of research asks a more direct question: across real published trials, does using them actually change the result?
- Aim: Page and colleagues (2016) aimed to synthesise the evidence on how far weak randomisation, poor allocation concealment, and lack of blinding bias trial results.
- Method: They combined 24 existing meta-epidemiological studies, each of which had already compared trial results with and without a given design feature. They then compared subjective outcomes, such as pain, against objective ones, such as mortality.
- Results: Unclear randomisation or allocation concealment exaggerated effects by roughly 7 to 10% on average. Unblinded trials exaggerated subjective outcomes, such as pain ratings, by around 23%; objective outcomes like mortality showed little to no exaggeration.
- Conclusion: Page and colleagues concluded that specific design flaws, especially inadequate blinding, inflate reported treatment effects, particularly for subjectively judged outcomes.
The pattern goes back further than 2016.
A large project replicated 100 studies from three major psychology journals. Only 36% reproduced the original result, and effect sizes roughly halved (Open Science Collaboration, 2015). In response, researchers proposed a package of reforms, including pre-registration, larger samples, and routine independent replication (Munafò et al., 2017).
Frequently Asked Questions
1. What is the difference between the control group and the experimental group in an experimental study?
Put simply, the experimental group receives the variable, or treatment, that the researchers are testing, whereas the control group does not. Both groups should be identical in all other respects.
2. What is the purpose of a control group in an experiment?
A control group is essential in experimental research because it:
Provides a baseline against which the effects of the manipulated variable (the independent variable) can be measured.
Helps to ensure that any changes observed in the experimental group are indeed due to the manipulation of the independent variable and not due to other extraneous or confounding factors.
Helps to account for the placebo effect, where participants’ beliefs about the treatment can influence their behavior or responses.
In essence, it increases the internal validity of the results and the confidence we can have in the conclusions.
3. Do experimental studies always need a control group?
Not all experiments require a control group, but a true “controlled experiment” does require at least one control group. For example, experiments that use a within-subjects design do not have a control group.
In within-subjects designs, all participants experience every condition and are tested before and after being exposed to treatment.
These experimental designs tend to have weaker internal validity as it is more difficult for a researcher to be confident that the outcome was caused by the experimental treatment and not by a confounding variable.
4. Can a study include more than one control group?
Yes, studies can include multiple control groups. For example, if several distinct groups of subjects do not receive the treatment, these would be the control groups.
Drug trials often use three arms: an active-treatment group, a no-treatment control, and a placebo control. Together they separate whether the drug worked from whether merely being treated worked.
5. How is the control group treated differently from the experimental groups?
The control group and the experimental group(s) are treated identically except for one key difference: exposure to the independent variable, which is the factor being tested. The experimental group is subjected to the independent variable, whereas the control group is not.
This distinction allows researchers to measure the effect of the independent variable on the experimental group by comparing it to the control group, which serves as a baseline or standard.
Key Takeaways
- Baseline Comparison: The control group is not exposed to the independent variable, so it shows what would have happened without the treatment.
- Random Allocation: Assigning participants to groups by chance spreads individual differences evenly, rather than matching people one by one.
- Positive vs Negative: A positive control confirms the procedure can detect a real effect; a negative control confirms nothing appears when it shouldn’t.
- Placebo Control: An inactive but identical-looking treatment isolates participants’ belief in the treatment from the treatment’s real, active effect.
- Modern Evidence: Large-scale reviews show that trials without proper randomisation or blinding report inflated effects, especially for subjectively judged outcomes.
- Waitlist Controls: Participants who wait for therapy improve less than those on usual care, which can exaggerate how well a therapy works.
References
Bailey, R. A. (2008). Design of comparative experiments. Cambridge University Press.
Beecher, H. K. (1955). The powerful placebo. Journal of the American Medical Association, 159(17), 1602–1606. https://doi.org/10.1001/jama.1955.02960340022006
Cuijpers, P., Miguel, C., Harrer, M., Ciharova, M., & Karyotaki, E. (2024). The overestimation of the effect sizes of psychotherapies for depression in waitlist controlled trials: A meta-analytic comparison with usual care controlled trials. Epidemiology and Psychiatric Sciences, 33, Article e56. https://doi.org/10.1017/S2045796024000611
Hatzigeorgiadis, A., Zourbanos, N., Mpoumpaki, S., & Theodorakis, Y. (2009). Mechanisms underlying the self-talk–performance relationship: The effects of motivational self-talk on self-confidence and anxiety. Psychology of Sport and Exercise, 10(1), 186–192. https://doi.org/10.1016/j.psychsport.2008.07.009
Hinkelmann, K., & Kempthorne, O. (2008). Design and analysis of experiments: Vol. 1. Introduction to experimental design (2nd ed.). Wiley.
Kobak, K. A., Taylor, L. V. H., Bystritsky, A., Kohlenberg, C. J., Greist, J. H., Tucker, P., Warner, G., Futterer, R., & Vapnik, T. (2005). St John’s wort versus placebo in obsessive–compulsive disorder: Results from a double-blind study. International Clinical Psychopharmacology, 20(6), 299–304. https://doi.org/10.1097/00004850-200511000-00003
Kohavi, R., Deng, A., Frasca, B., Walker, T., Xu, Y., & Pohlmann, N. (2013). Online controlled experiments at large scale. In Proceedings of the 19th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (pp. 1168–1176). ACM. https://doi.org/10.1145/2487575.2488217
Krause, M. S., & Howard, K. I. (2003). What random assignment does and does not do. Journal of Clinical Psychology, 59(7), 751–766. https://doi.org/10.1002/jclp.10170
Munafò, M. R., Nosek, B. A., Bishop, D. V. M., Button, K. S., Chambers, C. D., Percie du Sert, N., Simonsohn, U., Wagenmakers, E.-J., Ware, J. J., & Ioannidis, J. P. A. (2017). A manifesto for reproducible science. Nature Human Behaviour, 1, Article 0021. https://doi.org/10.1038/s41562-016-0021
Nelson, K. A., Mirzaei, S., Schlaeger, J. M., Li, H., Burke, L., Cabezas, P., Meinel, M., Rountree, L., Su, S., & DeVon, H. A. (2025). Designing an attention control condition for a randomized controlled trial using TED Talks. Western Journal of Nursing Research, 47(8), 764–769. https://doi.org/10.1177/01939459251342753
Open Science Collaboration. (2015). Estimating the reproducibility of psychological science. Science, 349(6251), aac4716. https://doi.org/10.1126/science.aac4716
Orne, M. T. (1962). On the social psychology of the psychological experiment: With particular reference to demand characteristics and their implications. American Psychologist, 17(11), 776–783. https://doi.org/10.1037/h0043424
Page, M. J., Higgins, J. P. T., Clayton, G., Sterne, J. A. C., Hróbjartsson, A., & Savović, J. (2016). Empirical evidence of study design biases in randomized trials: Systematic review of meta-epidemiological studies. PLOS ONE, 11(7), e0159267. https://doi.org/10.1371/journal.pone.0159267
Roethlisberger, F. J., & Dickson, W. J. (1939). Management and the worker. Harvard University Press.
Torgerson, C. J., & Torgerson, D. J. (2001). The need for randomised controlled trials in educational research. British Journal of Educational Studies, 49(3), 316–328. https://doi.org/10.1111/1467-8527.t01-1-00178
Wager, T. D., & Atlas, L. Y. (2015). The neuroscience of placebo effects: Connecting context, learning and health. Nature Reviews Neuroscience, 16(7), 403–418. https://doi.org/10.1038/nrn3976
